Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection
- 1 September 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 16 (3) , 359-366
- https://doi.org/10.1093/jac/16.3.359
Abstract
Cefuroxime axetil, an orally absorbed pro-drug of cefuroxime was used to treat a mainly elderly group of patients with symptomatic urinary tract infections. The drug was clinically effective and the bacteriological short term and long term cure rates (55% and 48% respectively) comparable to those of other antibiotics. The study had to be terminated however after the development of three cases of antibiotic associated colitis. Studies of the pharmacokinetics of the drug in volunteers gave inconsistent results suggesting that there may be variable bioavailability of the compound.Keywords
This publication has 3 references indexed in Scilit:
- Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infectionJournal of Antimicrobial Chemotherapy, 1984
- The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after foodJournal of Antimicrobial Chemotherapy, 1984
- Cefuroxime therapy for urinary tract infections caused by a multi-resistant, epidemic Klebsiella aerogenesJournal of Antimicrobial Chemotherapy, 1979